Volume Alert - EGO 6.26 Eldorado Gold Corp $EGO Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - EGO 6.26 Eldorado Gold Corp $EGO Hit a high today of 6.30 Closing the day 10:29 at 6.26 +0.06 +0.97% With a day low of 6.08 and a total volume of 1,828,614.

EGO Recent Posts: http://investorshangout.com/Eldorado-Gold-Corp-EGO-50846/

EGO Eldorado Gold Corp Recent Headline News

Eldorado Gold Disappoints On Earnings; Valuation Is Expensive
Christopher De Sousa - at Seeking Alpha - Fri Nov 14, 1:41PM CST

EGO: 6.27 (+0.07)

NYSE stocks posting largest percentage increases
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
NES: 8.43 (-0.35), PVG.TO: 6.28 (-0.09), AU: 9.26 (-0.30), FR.TO: 5.69 (-0.25), PVG: 5.64 (+0.02), SEA.TO: 7.90 (-0.18), AG: 5.02 (-0.26), P: 20.49 (-1.02), EGO: 6.27 (+0.07), ELD.TO: 7.09 (+0.08), MMS: 52.38 (-0.19), SA: 7.09 (-0.08)

Credit Suisse: Gold to be in deficit by 2016; AEM, EGO are top picks
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 9:58AM CST

GSS: 0.30 (+0.02), ABX: 12.32 (+0.04), EGO: 6.27 (+0.07), AEM: 25.36 (+0.25), AUQ: 3.86 (+0.08), KGC: 2.65 (-0.06), FNV: 52.93 (+0.41), NEM: 18.87 (-0.28), NGD: 4.11 (+0.03), IAG: 2.14 (+0.02), AGI: 7.57 (-0.01), AUY: 3.88 (+0.01), GG: 20.37 (-0.05)

Eldorado Gold Has Returned 20.8% Since SmarTrend Recommendation (EGO)
Comtex SmarTrend(R) - Thu Nov 13, 11:11AM CST
SmarTrend identified a Downtrend for Eldorado Gold (AMEX:EGO) on September 9th, 2014 at $7.40. In approximately 2 months, Eldorado Gold has returned 20.76% as of today's recent price of $5.86.
EGO: 6.27 (+0.07)

Gold Stocks Technical Snapshot - Newmont Mining, Eldorado Gold, Royal Gold, Sibanye Gold, and Primero Mining
PR Newswire - Thu Nov 13, 8:20AM CST
Investor-Edge has initiated coverage on the following equities: Newmont Mining Corporation (NYSE: NEM), Eldorado Gold Corporation (NYSE: EGO), Royal Gold Inc. (NASDAQ: RGLD), Sibanye Gold Ltd (NYSE: SBGL), and Primero Mining Corporation (NYSE: PPP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, November 12, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,612.20, down 0.02% and the NASDAQ Composite closed at 4,675.14, up 0.31%. The S&P 500 finished the session 0.07% lower at 2,038.25. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 308.58, up 0.19%, with the index advancing 5.79% in the last one month. Register for your complimentary reports on these five stocks at:
EGO: 6.27 (+0.07), NEM: 18.87 (-0.28), RGLD: 67.78 (-0.12), PPP: 3.68 (+0.03), SBGL: 6.99 (-0.06)

Eldorado Gold Rises 9.06% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Nov 11, 4:38PM CST
Eldorado Gold (AMEX:EGO) traded in a range yesterday that spanned from a low of $5.36 to a high of $5.92. Yesterday, the shares gained 9.1%, which took the trading range above the 3-day high of $5.67 on volume of 8.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EGO: 6.27 (+0.07)

Look for Shares of Eldorado Gold to Potentially Pullback after Yesterday's 9.06% Rise
Comtex SmarTrend(R) - Tue Nov 11, 4:37PM CST
Eldorado Gold (AMEX:EGO) traded in a range yesterday that spanned from a low of $5.36 to a high of $5.92. Yesterday, the shares gained 9.1%, which took the trading range above the 3-day high of $5.67 on volume of 8.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EGO: 6.27 (+0.07)

Eldorado Gold (EGO) Stock Rises as Gold Prices Climb
at The Street - Tue Nov 11, 2:10PM CST
Shares of Eldorado Gold (EGO) surged in afternoon trading Tuesday as gold prices rebounded from Monday's decline.
EGO: 6.27 (+0.07)

Eldorado Gold (EGO) Is Today's Dead Cat Bounce Stock
at The Street - Tue Nov 11, 8:46AM CST
Trade-Ideas LLC identified Eldorado Gold (EGO) as a "dead cat bounce" (down big yesterday but up big today) candidate
EGO: 6.27 (+0.07)

Eldorado Gold (EGO) Stock Falls as Gold Prices Dip Again
at The Street - Mon Nov 10, 2:08PM CST
Shares of Eldorado Gold (EGO) fell in afternoon trading Monday to give up some of the gains it made Friday after gold prices briefly rallied.
EGO: 6.27 (+0.07)

Earnings Look Back: Eldorado Gold Is Down 6.9% Since Reporting Quarterly Results 1 Week Ago (EGO)
Comtex SmarTrend(R) - Mon Nov 10, 1:37PM CST
11 days ago, on October 30th, 2014, Eldorado Gold (AMEX:EGO) reported its earnings. Analysts, on average, expected earnings of $0.06 per share on sales of $279.6 million. The company actually reported a break-even quarter on sales of $263.5 million, missing EPS estimates by $0.06 and missing revenue estimates by $16.1 million. Shares of Eldorado Gold have slipped from $6.06 to $5.64, representing a loss of 6.9%, since the company reported earnings 11 days ago.
EGO: 6.27 (+0.07)

Dismal Year For Gold Stocks May Present Opportunity For Patient Investors
Michael Blair - at Seeking Alpha - Sun Nov 09, 2:18AM CST

BTG: 1.69 (-0.02), G: 17.97 (+0.09), EGO: 6.27 (+0.07)

Insiders Are Not Buying These Gold Mining Stocks
Prudent Finances - at Seeking Alpha - Fri Nov 07, 1:22PM CST

EGO: 6.27 (+0.07), AEM: 25.36 (+0.25), ABX: 12.31 (+0.03), GOLD: 67.66 (-1.09), FNV: 52.93 (+0.41), SLW: 20.44 (+0.25), NEM: 18.87 (-0.28), RGLD: 67.78 (-0.12), GDX: 19.01 (-0.01), GG: 20.37 (-0.05)

Eldorado Gold Shares Down 29.1% Since SmarTrend's Sell Call (EGO)
Comtex SmarTrend(R) - Thu Nov 06, 9:52AM CST
SmarTrend identified a Downtrend for Eldorado Gold (AMEX:EGO) on September 9th, 2014 at $7.40. In approximately 2 months, Eldorado Gold has returned 29.14% as of today's recent price of $5.24.
EGO: 6.27 (+0.07)

November 2014 Gold Report
ACCESSWIRE - Wed Nov 05, 2:35PM CST
CORAL GABLES, FL / ACCESSWIRE / November 5, 2014 / How do we know what to expect the price of gold to do when it stops acting like gold? During times of crisis we could always expect the price of gold to rise. Everyone gets scared of holding on to all that paper money so they trade it in for gold, put it under their mattress, and sleep on a lumpy bed. Well not these days. Banking issues well we have some of those to go around as well. The European Central Bank reviewed 130 banks of which 13 were found to have capital shortfalls. Those banks have until next Monday to explain to the central bank how they will raise the necessary capital. Some might say that the price of gold is expected to be low considering the hawkish tone from the Federal Reserve and the way the labor market has been looking recently. It is also true that investors move away from gold into stocks when the economic outlook picks up steam.
EGO: 6.27 (+0.07), ABX: 12.31 (+0.03), SAND: 2.91 (+0.02)

Update: Eldorado Gold Earnings
The Investment Doctor - at Seeking Alpha - Tue Nov 04, 12:49AM CST

EGO: 6.27 (+0.07)

Eldorado Gold (EGO) CEO Paul Wright on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 11:37PM CST

EGO: 6.27 (+0.07)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles